Background: The scattered nature of sensitive health information can bring about situations where timely information is unavailable, worsening health outcomes. Furthermore, as patient involvement in healthcare increases, there is a growing need for patients to access and control their data. Blockchain is a secure decentralised online ledger that could be used to manage electronic health records efficiently, and so improve health outcomes by enabling interoperability. Objective: To perform a systematic review to assess the feasibility of blockchain as a method of managing healthcare records efficiently. Methods: Reviewers identified studies via systematic searches of databases including Pubmed, Medline, Scopus, Embase, Proquest and Cochrane Library. Suitability for inclusion of each was assessed independently. Results: Of 71 included studies, the majority discuss potential benefits and limitations without evaluation of their effectiveness, although some systems were tested on live data. Conclusions: Blockchain can efficiently manage access to electronic health records stored on the cloud. Using a blockchain can increase interoperability without compromising privacy and security of data. It contains inherent integrity, and conforms to strict legal regulations. Increased interoperability would be beneficial for health outcomes. While this technology is currently unfamiliar to most, investments into creating a sufficiently user-friendly interface and educating users on how best to take advantage of it would also improve health outcomes.
INTRODUCTION
Medical records in Britain comprise legacy paper records and numerous disconnected electronic systems. Despite the advancement of other fields in using technology, there remains a lack of interoperability in healthcare systems arising from the non-uniform record storage methods, that restricts doctors in their capacity to provide appropriate care. Furthermore, the lack of (correct) information has been considered the primary cause of problems in healthcare, leading to medical errors and adverse events. A blockchain is a decentralised online ledger (database), first implemented to store an everincreasing record of all transactions using the cryptocurrency Bitcoin. The system is also flexible enough to allow the addition of arbitrary logic to process, validate and access the data. This is implemented via components of business logic known as smart contracts, which reside on the blockchain and are synchronised across all nodes. A smart contract is a string of computer code that executes whenever certain conditions are met, ensuring security and authorised access. ] Information exchange using smart contracts is transparent and conflict-free, and eliminates the need for a middleman as the blockchain executes the data sharing based on the conditions of the contract. [29, 43] Ownership and privacy of data are important issues that blockchain could solve. It is currently unclear whether the healthcare provider or the patient owns healthcare data relating to a patient, although patients have a definite right to access the data. In addition to ownership issues, with the introduction of GDPR, it is important for patients to know how their personal information is being handled. [10, 13 ] Smart contracts implemented by a blockchain would simplify the consent process for data access by doctors. The current consent process is not standardised or personalised, which makes it difficult for a patient to express his/her access control policy, which may for example involve allowing selected access to particular specialists.
Another concern with medical records is the cost currently associated with transferring records between locations. ] and there is clear inefficiency inherent in transcribing a digital asset onto optical media which is commonly read only once at the receiving site. [11, 17 ] A system integrating patient consent as well as access to authorised individuals would save on these costs.
Medical information is no longer limited to written reports, imaging studies and blood tests.
Genomic data and that collected by wearable devices, such as bracelets and watches embedded with sensors, are increasingly accumulated. These may lead to improved treatment options and outcomes, and may also be examined by health insurance companies offering discounts for 'healthy' behaviour. Further benefits arise in the realm of artificial intelligence. This can infer trends from the data that are then used to generate populationlevel insight, and so achieve population health as a whole. These new data formats require careful integration, to allow appropriate analysis while maintaining patient privacy and security from hackers.
While digitisation of health records has been in place in the GP sector for over thirty years (albeit lacking essential data sharing and exchanging capabilities), secondary care has not yet successfully achieved this de facto standard. Distributed ledger technology, initiated and exemplified by the Bitcoin blockchain, is having a growing impact on information technology environments in which conformation to legislative regulations and maintenance of public trust are increasingly paramount, [ 18 ] and it may be used in realising NHS Digital's target. The aim of this review is to summarise the evidence relating to the implementation of blockchains to manage electronic health records, and to discuss whether this would improve efficiency of record management.
METHODS
The protocol [ 19 ] was used with the following modifications: -The research question was modified to focus on efficiency, as the issues of privacy and scalability would broaden the review excessively.
-Five additional search databases were included to account for the potential lack of published research on the topic.
-The population was extended to include anyone whose data is stored in a healthcare blockchain. It was also noted that much of the literature would consist of unimplemented frameworks, so would have no population. Efficiency: Either improved administrative capabilities or cost-effectiveness, or improved health outcomes as a result of these.
Research question and definitions

What
Current methods: These may consist of traditional paper-based methods or more advanced technology adopted to provide more coordinated healthcare.
Search strategy and study selection
We searched Pubmed, Scopus, Embase, Medline, Proquest, CINAHL, AMED, Global Health, Books@Ovid and Cochrane Library for all relevant literature including articles, theses and conference abstracts that have been published electronically. We also searched for other systematic reviews on the topic using PROSPERO. Table 1) . As blockchains applied to the healthcare sector remains a novel approach, we did not place restrictions on the study type. Nor were restrictions placed on dates of publication or geographic locations. However, only studies in English were included.
Results of the search strings (Supplementary Table 2 ) were imported into EndNote X8.0.1 (Clarivate Analytics), which was used to remove duplicate articles. Remaining duplicates were deleted manually. Potentially eligible articles were identified using an iterative approach of full text screening followed by title and abstract searches (Supplementary Table   3 ). These were exported into Microsoft Excel, and the title and abstract of each was independently screened by two reviewers, based on the following inclusion criteria:
-Articles must discuss the use of blockchain to manage medical records in some manner
AND -Articles must describe the benefits and/or disadvantages of using this technology [and compare this to currently used methods of managing medical data]
Where the second point may not be determined from the abstract alone, the study should be taken to full text screening. Studies may not identify a comparator, and these may be included provided the remaining inclusion criteria are met. Table 4) , and no adjudication from a third reviewer was required. The full texts of the remaining articles were subsequently assessed for their eligibility, based on the same eligibility criteria. This selection process is demonstrated using the PRISMA flow diagram (Supplementary Figure A) .
Reviewers resolved discrepancies through discussion (Supplementary
Data extraction
A template was designed to collect information required to address the research question.
Basic information was collected automatically by Endnote, and the remaining data items (Supplementary Table 5 ) were gathered after reading the papers in full.
Outcomes
The primary outcome measures were interoperability and cost-effectiveness (our definition of primary efficiency). The secondary outcome measure was improved health outcomes, although it was noted that it might be difficult to determine a quantitative measure of this with respect to blockchains.
Strength of evidence and data synthesis
Studies of interventions involving randomised and non-randomised methods were assessed for risk of bias using the Cochrane Collaboration Risk of Bias Tool and the Risk of Bias in NonRandomised Studies -of Interventions (ROBINS-I) tools respectively.
The extracted data were subsequently summarised qualitatively. No meta-analysis was performed, because application of blockchains in healthcare remains a novel method and articles with sufficient numerical data were not found. In addition, the heterogeneity of studies prevented a meta-analysis.
RESULTS
Description and characteristics of included studies
After the initial literature search, removal of duplicates, eligibility and full-text screening, 61 articles were included in the paper. An additional ten papers were added via snowballing of the full texts screened (Table 1) . 
Description of company in the field 20 (Table 2) Newspaper, magazine, columns 19 in searched databases, many more online Only very few articles described the implemention of a blockchain system to real world medical data, highlighting the novelty of this technique. One of these [23] used smart contracts to manage access to medical data that was stored on the cloud, while the others stored medical data directly on the blockchain. Of the largest group of articles, which proposed a framework (without implementing it), the majority advocated cloud-based data storage and blockchain-based access control. In addition to the primary outcome of interoperability, issues considered in these papers included those of privacy and data security, scalability and administrative affairs. There were also number of companies identified which are currently implementing blockchains in healthcare (Supplementary Table   7 ), many of which have not published any academic literature.
The majority of the information comparing blockchain's potential versus current methods of managing records was found in opinion articles, which were set more broadly in the context of developments in healthcare technology. Many described the disarray of current health record management. Some used the successes of blockchain in other fields than healthcare and finance to demonstrate its versatility.
Outcome measures
Interoperability was seen as feasible using a blockchain approach, if the blockchain is used for access control (as opposed to sensitive data storage). The approach was cost effective compared to administrative costs of transporting records. Administrative difficulties and costs may arise in collating legacy data, although these would be accounted for in savings from improved health outcomes in the long term.
DISCUSSION
Summary of evidence
A blockchain can allow improved interoperability as data across multiple systems can be accessed simultaneously and immediately. The interfacing of different systems would also save costs. [33] These factors reduce administrative delays, as does the use of smart contracts to execute patients' consent preferences immediately. An off blockchain data repository ('data lake') is scalable and can store a variety of data types, as well as being a tool for research. It is interactive and supports high throughput data analysis and machine learning, while being encrypted and digitally signed to ensure data privacy and authenticity.
[39] The collaboration between patients, doctors, and researchers arising from a blockchainbased system allows for a greater degree of exchange and comparison, leading to specific and personalised care pathways. [18, 33] The ONC has described several features critical to 
Integrity
The immutability of a blockchain that stems from linking the hashes of subsequent blocks, carries with it inherent integrity, as blocks cannot be rewritten without collaboration of a majority of nodes. This property was exemplified by RadBit at last year's Yale Healthcare
Hackathon.
[34] Potential ways to improve the integrity are to use blind signatures, which reinforce protection from tampering as well as confirming the sender's and viewer's identities, [42] or to use signatures from multiple authorities. 
ONC Blockchain Challenge
In 2016, the ONC organised the "Use of Blockchain in Health IT and Health-Related
Research" challenge, seeking ideas to address the difficulties of managing health records. [9, 52 , 63] Winning papers described innovative ways to securely empower patients through interoperability. [47, 53 ] MedRec, one of the winning entries, is now being implemented in
Boston. This proposal from MIT's Media Lab involves associating a medical record with viewing permissions and data retrieval instructions for execution on external databases, thus using the blockchain to record patient provider interactions via smart contracts. 
Real world implementation
Blockchain has been adopted on a large scale by the Estonian government, in collaboration with Guardtime, where it secures millions of records. Other companies involved in introducing blockchain to everyday healthcare include Medicalchain, which allows users to sign up and use the interface to interact with their GP, Patientory, that connects doctors, health providers and consumers, and others listed in Supplementary Table 7 .
CHALLENGES AND LIMITATIONS
Data Ownership and Privacy
Achieving interoperability depends on patients taking control of their data and deciding on how it is to be used. Shifting data ownership from the government and companies to patients would require extesive reengineering of legacy systems, but would incentivise patients to become active agents in their own care by contributing data in order to get the best possible treatment. [4, 55 , 56 ] It would also give them the sole power to authorise data access to various providers at their discretion, [28] eliminating delays associated with the current bureaucracy, [40, 50, 57 ] and ensuring patient privacy. [10] Patients could also selectively share data with researchers, either for the greater scientific good or to enable studies on their unique condition.
[
The system would guarantee their consent. A recent example, 23andMe, 80% of whose users chose to make their genomic data available to researchers, demonstrates that patients will be happy to share data for research should they stand to benefit. Enabling direct patient involvement in controlling the use of their records in this open and secure manner will enhance the uptake of such platforms and potentially lead to improved health outcomes. [18] In addition to sharing data, which may be accomplished with a trusted system, there is the idea of 'rewarding' patients for healthy behaviour, such as with lower insurance premiums. [10, 46] Legal Under GDPR (Article 17), the OECD privacy guideline, the HIPAA Privacy Rule and others, [48] individuals may request for their data to be erased. However, a record of the data's existence would still be maintained within the chain, even if the data itself were to be deleted from the cloud. The legal question arising from this relates to whether metadata of personal data classifies as personal data. [44] Were a private or consortium-led blockchain to be used, these privacy concerns would be addressed (as well as those of security and scalability).
However they may not be vendor neutral or have open standards, [38, 39] issues which would have to be dealt with by the respective governing authority. These sorts of regulatory constraints are necessary to ensure appropriate use of information, however they may slow development in the field. HIPAA, for example, requires that an institutional review board approve the use of data. [10] Security Sensitive data must be kept safe from eavesdroppers and intruders. [28, 59 ] Breaches have a negative impact on the public perception of the healthcare field, and threaten to hinder ] Thus to realise the advantages of a decentralised system, patients must have some trust that at least 50% of mining nodes
would not want to violate the immutability of the blockchain. The public blockchain also leads to the possibility of deanonymisation, which would need to be avoided by pseudonymising data in order to protect patients' identities. [11, 46] If a private or consortium blockchain were to be used however, mining nodes would be limited to hospitals and other trusted health providers, eliminating these security flaws.
Other concerns
While the major concerns with blockchain are those of security, privacy and legal restrictions, for which various workarounds have been developed, there remain some further challenges to consider. Firstly, consolidating data from legacy systems will involve removing data that is duplicated in different parts of the system, [4] any system, it is necessary for users to input good quality information: the trustworthiness arising from blockchain's immutability and decentralisation concedes to the input of low quality (incorrect) information. [4, 27] . Thirdly, the issue of currency, used in blockchain to incentivise users to mine blocks in the new network. An ICO [33, 41, 47] could initiate this process by valuing the new token as funds are raised. [47] However extremes of price could deter miners, and so mining may need to be restricted to healthcare providers to avoid this.
Another view is to remove all currency, as data is owned by the patient and is not in itself an exchangeable currency. [29] Based on this, we may assume that providers already have an incentive to secure patients' medical information, and so there would be no need to incentivise mining beyond the simple use of the system. Finally, the reliance of a blockchain on essentially arbitrary computation could be seen to introduce administrative inefficiency.
[18] Transactions are therefore energy intensive, as each must be computationally verified and validated by the whole network.
[33] Such a mechanism is still beneficial however, as rather than providing economic value it demonstrates proof-of-participation, which would be required for ongoing use of the system.
CONCLUSION
The storage and sharing of medical data (developing interoperability) are vital for improved health outcomes. Respecting privacy of sensitive information while doing this remains a big challenge in healthcare. The literature show that with the appropriate regulatory guidelines and use standards, blockchain can act as a vehicle to manage consented access to electronic health records. This will increase interoperability without compromising security, and while also protecting patient privacy. These issues would most effectively be tackled by the use of a private or consortium-led blockchain, however this would need to be regulated to ensure appropriate use of data. The improved interoperability and reduced long term administrative costs would lead to improved health outcomes.
Blockchain represents a new form of technology on which the current literature is expectedly poor, and no usage feedback or statistical comparisons with traditional systems
exists. There are costs associated with transferring to a new system, and in educating health professionals and patients on how best to take advantage of it for improved health.
Blockchain involves concepts unfamiliar to the vast majority of the population, such as cryptographic signature and key management. Investments into the new system would however be outweighed through returns. In the primary stages of implementation, the practical usefulness of the proposed system will likely depend on the end user experiencethe complexities underlying the blockchain will need to be hidden behind a sufficiently userfriendly interface such as an online or mobile application in order to be adopted successfully.
Short term trials will outline the most effective ways to implement such a user-friendly experience, which may be expanded thereafter.
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